GLAXOSMITHKLINE PLC (NYSE: GSK)

Sector: Medical

Current Price : $52.21

52 Week Low
$41.9052 Week High
$52.21

Technicals

Press Releases
BREO(TM) ELLIPTA(TM) Gains US Approval for the Treatment of COPD
GlaxoSmithKline, Triangle Community Foundation Issue Call for Applications Totaling $400,000 in GSK IMPACT Awards
GlaxoSmithKline Issues Call for Applications Totaling $400,000 in GSK IMPACT Awards
GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive Today
GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive
Texas A&M System and GlaxoSmithKline receive U.S. Government approval to establish influenza vaccine facility in Texas
The Real Story Behind MSI, SNE, GSK and UBS
A Forward Look, The Year Ahead - Research Report on Multimedia Games Holding Company Inc., SHFL entertainment Inc., Oracle Corporation, Adobe Systems Incorporated and GlaxoSmithKline plc.
Regulatory Update -- Stiefel, a GSK company announces a new, alternate, fixed-dose combination of Duac? (clindamycin 1% and benzoyl peroxide 3%) gains positive recommendation for approval in Europe
The Year Ahead, A Forward Look - Research Report on General Mills, Inc., GlaxoSmithKline plc., Pfizer Inc., The Coca-Cola Company and Dr. Pepper Snapple Group, Inc.
StockCall Review on Dynavax and GlaxoSmithKline: Pharma Stocks Bet on Drug Approvals
Free Research Report on Sina Corp., Danaher Corp., GlaxoSmithKline plc and TECO Energy, Inc.
GlaxoSmithKline progresses multi-city discussion focused on improving the health of US communities
Key to Success, How to Profit: TLM, DEO, and GSK
The Reason It Trades, What's Moving NWSA, CPNO, GSK and HAE
Perfect Trade Setups, How to Play CELG, NVS, GSK and BMY
The Real Story Behind ABT, HLF, PFE and GSK
FDA Approves GlaxoSmithKline's four-strain seasonal influenza vaccine for use in the U.S.
GSK receives FDA approval for raxibacumab anti-toxin for the treatment of inhalational anthrax
The Real Story Behind GSK, ADBE, BK and BP
GlaxoSmithKline advances multi-city discussion focused on improving the health of US communities
FDA approves new indication for PROMACTA? (eltrombopag)
GSK Responds to Hurricane Sandy Relief Needs
Efficacy Shown With GlaxoSmithKline's Phase 3 Malaria Vaccine Candidate, Which Contains Agenus' Qs-21 Stimulon(R) ADJUVANT
GlaxoSmithKline honors healthcare nonprofits with $40,000 IMPACT Award
ViiV Healthcare commits nearly ?4M in Positive Action for Children Fund grants for programmes focused on alleviating burden of HIV on women and children
GlaxoSmithKline Sales Down in Q3 against Good Underlying Momentum in the Business
GlaxoSmithKline Launches New Program to Help Consumers Recycle Empty GSK Respiratory Inhalers
NuPathe Announces Closing of $28 Million Private Placement and Changes to Its Board of Directors
Traders Look to New Levels Ahead - Research & Analysis on Amgen Inc. and Glaxosmithkline Plc
Market Influences That Drive Equities Forward - Industry Report on Abbott Laboratories and Glaxosmithkline Plc
Stiefel receives US FDA approval of Sorilux(tm) Foam, 0.005% for topical treatment of plaque psoriasis of the scalp
Equity Research on Abbott Laboratories and GlaxoSmithKline plc - Drug Makers Contending With Development Costs
Pfizer and GlaxoSmithKline Rise After Moody's Upgrades Pharmaceutical Industry Outlook to "Stable"
GSK and Theravance Announce FDA Acceptance of FF/VI New Drug Application (NDA) Submission in the US for COPD
GlaxoSmithKline initiates a multi-city conversation focused on improving the health of US communities
Pharmaceutical Companies Begin to Offer Copayment Coupons to Help Compete With Generic Versions of Top Selling Drugs
GlaxoSmithKline shipping U.S. flu vaccine with new strain coverage recommended for 2012-2013
Once-Daily Dolutegravir is Non-Inferior to Twice-Daily Raltegravir in Treatment-Naive Adults with HIV-1
GSK CEO Sir Andrew Witty Interviewed on Q2 2012 Results
ViiV Healthcare Expands Commitment to Addressing Gaps in Paediatric HIV Research, Care and Treatment
Amicus Therapeutics and GlaxoSmithKline Expand Fabry Disease Collaboration
GSK and Theravance Announce Regulatory Submissions for FF/VI in the US and Europe
Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV
GlaxoSmithKline concludes previously announced agreement in principle to resolve multiple investigations with US Government and numerous states
Whistleblowers played major role in Glaxo case, leading to Glaxo's record settlement
Research on Abbott Laboratories and GlaxoSmithKline plc - Approvals and Testing Dominate Drug Manufacturers' News
GlaxoSmithKline Employees Embark on Long-Term Volunteer Assignments throughout the World
GSK Receives FDA Approval for MenHibrix?
Equities Lead Investor Sentiment - Research Report on Abbott Laboratories and GlaxoSmithKline plc (ADR)
Upcoming Economic Outlook - Report Highlights GlaxoSmithKline plc (ADR) and Bristol Myers Squibb Co.
Plan to Speed Up FDA Reviews Recently Approved by Senate
Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co-Promotion Agreement for Testim? in the U.S.
More Dividend Paying Companies on the S&P Index Than Ever Before
Stiefel receives US FDA approval of Fabior(tm) Foam, 0.1%
FDA approves Votrient? for treatment of patients with certain types of advanced soft tissue sarcoma
Shionogi-ViiV Healthcare Announces Initial Data from Pivotal Phase III Study of Dolutegravir in HIV
Analytical Reports on Abbott Laboratories and GlaxoSmithKline plc - Drug Manufacturers Facing Headwinds
GSK Announces Positive Vote From FDA Panel for Pazopanib in Certain Advanced Soft Tissue Sarcomas
GlaxoSmithKline Invites Philadelphia Area and City of Camden Healthcare Nonprofits to Apply for $40,000 IMPACT Awards
Major Pharmaceutical Stocks Performing Strong in Volatile Market
Pfizer and GlaxoSmithKline Look to Curb Costs as Generic Competition Cuts Into Revenues
Siemens Forms New Companion Diagnostics Partnerships with ViiV Healthcare and Tocagen
GSK Upbeat on Solid Results - Interviews with CEO and CFO
A Forward Look, the Year Ahead - Featured Research on Amarin Corporation plc (ADR) and GlaxoSmithKline plc (ADR)
Pfizer and GlaxoSmithKline Optimistic on Growth Prospects
The New England Journal of Medicine Publishes Study Showing LigoCyte's Norovirus Vaccine Demonstrates Protection Against Illness
Direction of Market Influences - Report Highlights GlaxoSmithKline plc (ADR) and Eli Lilly & Co.
Genetic Technologies Limited Announces Quarterly Activities Report for the Quarter Ended 30 September 2011
Research on GlaxoSmithKline plc and Merck & Co. Inc. -- Big Pharma Stable for Now
Investors to Challenge James Murdoch's Other Directorships Following Today's News Corp AGM
First Results From Ongoing Phase III Trial Show Malaria Vaccine Candidate, RTS,S* Reduces the Risk of Malaria by Half in African Children Aged 5 to 17 Months
ViiV Healthcare's Positive Action for Children Fund Announces 16 New Grantees for the Year 2011/2012
ViiV Healthcare Starts Phase III Clinical Programme of Celsentri/Selzentry? (maraviroc) versus Truvada? (tenofovir + FTC), in combination with a Protease Inhibitor in people living with HIV
Isis Selects Development Candidate, Isis-AATRx, to Treat AATD-Associated Liver Disease
Pertussis booster for those age 65-plus
Unilife Develops Proprietary Self-Injection System
Regulatory Update: GSK and XenoPort Submit Supplemental New Drug Application to FDA for Horizant(tm) in Postherpetic Neuralgia
'Ghostwritten' medical study alleged
Elderly get whooping cough vaccine
GlaxoSmithKline Receives FDA Approval for BOOSTRIX? to Help Prevent Whooping Cough in Adults 65 Years and Older
/C O R R E C T I O N -- Synaptic Digital/
Video from GlaxoSmithKline and Synaptic Digital: GlaxoSmithKline Receives FDA Approval for BOOSTRIX? to Help Prevent Whooping Cough in Adults 65 Years and Older
GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
Valeant and GlaxoSmithKline Announce U.S. FDA Approval of Potiga(tm) (ezogabine)
Equity Research on GlaxoSmithKline plc and Johnson & Johnson - Several Promising Trends for Drug Manufacturers - Major Sector
Isis Earns $3 Million Payment as Collaboration With GSK Expands
Judge acquits GSK lawyer
Isis Pharmaceuticals' and GSK's Innovative Collaboration Voted Breakthrough Alliance of 2011
Doctors, patients recall visit differently
New Survey Finds Gap in Doctor-Patient Migraine Communication
FDA petitioned to remove Alli, Xenical
GlaxoSmithKline Confirms alli's Safety Profile
GlaxoSmithKline and XenoPort Receive FDA Approval for Horizant(TM)
Maven Semantic: Analgesia Research Database
GSK Publishes Payments for Research, Consulting and Advising by U.S. Healthcare Professionals
Fitch: Rating Changes Unlikely for Quest Diagnostics After Celera Buy
First new lupus drug in 50 years

iStock Rating

GLAXOSMITHKLINE PLC (NYSE: GSK)

Sector: Medical

Company

Community

Analysis

Charts

Analyst

Ratios